Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681200 · ClinicalTrials.gov registry record · NA
Evaluating Mechanisms of Blood Pressure Reduction Using Meditation in Hypertensive African Americans
A NA study, sponsored by Maharishi International University.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT00681200: Completed NA study, sponsored by Maharishi International University.
NCT00681200 is a NA study that has completed, run by Maharishi International University. The registered enrollment target is 152 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00681200, a NA study, has completed, sponsored by Maharishi International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
High blood pressure is a common health problem among people in the United States. This study will compare the effectiveness of a meditation program versus a health education program at decreasing stress and lowering blood pressure levels among African-American adults with high blood pressure.
Interventions
- BEHAVIORAL Enhanced health education
- BEHAVIORAL Transcendental Meditation program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT00681200 record still lists
NCT00681200 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced health education is the first listed.
NCT00681200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00681200 about?
NCT00681200 is a clinical study titled "Evaluating Mechanisms of Blood Pressure Reduction Using Meditation in Hypertensive African Americans". High blood pressure is a common health problem among people in the United States. This study will compare the effectiveness of a meditation program versus a health education program at decreasing stress and lowering blood pressure levels among African-American adults with high blood pressure.
What is the current status of trial NCT00681200?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2008-04. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00681200?
The interventions under investigation include: Enhanced health education (BEHAVIORAL), Transcendental Meditation program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00681200?
This trial is sponsored by Maharishi International University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00681200's enrollment target sits among peer trials
152 658th of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia